← Back to Analyst Consensus 
INTS Buy
INTENSITY THERAPEUTICS, INC.
Current Price —
Implied Upside —
Analysts 11
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 18, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Aug 20, 2025 | Benchmark | maintain | Speculative Buy → Speculative Buy | $1.5 | 54% |
| Aug 12, 2025 | Brookline Capital | upgrade | Hold → Buy | $3 | 38% |
| Jan 13, 2025 | Alliance Global Partners | initiate | — → Buy | $8.5 | 41% |
| Nov 21, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Oct 31, 2024 | HC Wainwright & Co. | initiate | — → Buy | $5 | 44% |
| Jul 11, 2024 | Benchmark | reiterate | Speculative Buy → Speculative Buy | $12 | 54% |
| May 16, 2024 | Benchmark | reiterate | Speculative Buy → Speculative Buy | $12 | 54% |
| Mar 21, 2024 | Benchmark | reiterate | Speculative Buy → Speculative Buy | $12 | 54% |
| Nov 14, 2023 | Benchmark | reiterate | Speculative Buy → Speculative Buy | $12 | 54% |
| Aug 24, 2023 | Benchmark | reiterate | Speculative Buy → Speculative Buy | $12 | 54% |
| Jul 18, 2023 | Benchmark | initiate | — → Speculative Buy | $12 | 54% |
Price Target Trend
Mar 30, 2026 Oct 26, 2026
EPS Estimates
+1y —
0q —
+1q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days